A stochastic model describes the heterogeneous pharmacokinetics of cyclosporin

被引:14
作者
Claret, L [1 ]
Iliadis, A
Macheras, P
机构
[1] Univ Montreal, Fac Pharm, Chair Populat Pharmacokinet, Montreal, PQ H3C 3J7, Canada
[2] Univ Mediterranee, UPRES EA 3286, Marseille, France
[3] Univ Athens, Sch Pharm, Athens, Greece
关键词
stochastic modeling; pharmacokinetics; cyclosporin; heterogeneity;
D O I
10.1023/A:1012295014352
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmacokinetics of cyclosporin (CsA) are unusual because of several heterogeneous features which include the presence of more than one conformer, considerable accumulation, in erythrocytes and lipoproteins, extensive plasma protein binding, distribution into deep tissues, biliary secretion and hepatic clearance involving a large number of metabolites. In this study, a stochastic compartmental model was developed to describe the heterogeneous elimination kinetics of CsA. This new approach relies on a probabilistic transfer model with a gamma distributed probability intensity coefficient for drug elimination. For comparative purposes both the stochastic model and compartmental deterministic models were fitted to real post infusion data from patients receiving CsA as a 2-hr intravenous infusion. The criteria for selecting the best model showed that the stochastic model, although simpler than the compartmental deterministic models, is more flexible and gives a better fit to the kinetic data of CsA than the compartmental deterministic models. The stochastic model with a random rate intensity coefficient adequately describes the heterogeneous pharmacokinetics of CsA.
引用
收藏
页码:445 / 463
页数:19
相关论文
共 38 条
[1]   NEW LOOK AT STATISTICAL-MODEL IDENTIFICATION [J].
AKAIKE, H .
IEEE TRANSACTIONS ON AUTOMATIC CONTROL, 1974, AC19 (06) :716-723
[2]  
[Anonymous], 1992, DENSITY ESTIMATION S
[3]  
[Anonymous], 1993, STAT DISTRIBUTIONS
[4]   A 50-year retrospective: Cell-mediated immunity and the major histocompatibility complex [J].
Bach, FH .
TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) :16-17
[5]  
BASSINGTHWAIGHT.JB, 1994, FRACTAL PHYSL
[6]   PHYSIOLOGICAL MODELING OF CYCLOSPORINE KINETICS IN RAT AND MAN [J].
BERNAREGGI, A ;
ROWLAND, M .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1991, 19 (01) :21-50
[7]   A population pharmacokinetic model of cyclosporine in the early postoperative phase in patients with liver transplants, and its predictive performance with Bayesian fitting [J].
Charpiat, B ;
Falconi, I ;
Breant, V ;
Jelliffe, RW ;
Sab, JM ;
Ducerf, C ;
Fourcade, N ;
Thomasson, A ;
Baulieux, J .
THERAPEUTIC DRUG MONITORING, 1998, 20 (02) :158-164
[8]  
D'Argenio DZ., 1991, ADV METHODS PHARMACO
[9]   MICHAELIS-MENTEN KINETICS DETERMINE CYCLOSPORINE STEADY-STATE CONCENTRATIONS - A POPULATION ANALYSIS IN KIDNEY-TRANSPLANT PATIENTS [J].
GREVEL, J ;
POST, BK ;
KAHAN, BD .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (06) :651-660
[10]  
*HARWELL, 1992, HARW SUBR LIB